Ovarian cancers show the highest prevalence of BRCA1/2 mutations at 21% [3] but ~5% in several other cancers, such as breast [4], prostate [5], non-small cell lung [6], pancreatic [7], bile duct [8], and bladder [9]. This evidence concerns the gene BRCA1 and cancer.